These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23331292)

  • 1. Comments on 'what is a rational antidepressant treatment for major depression in patients with Parkinson's disease?'.
    Pae CU
    Psychiatry Clin Neurosci; 2013 Jan; 67(1):65-6. PubMed ID: 23331292
    [No Abstract]   [Full Text] [Related]  

  • 2. What is a rational antidepressant treatment for major depression in patients with Parkinson's disease?
    Hagikura M; Iwamoto K; Aleksic B; Ozaki N
    Psychiatry Clin Neurosci; 2012 Aug; 66(5):463. PubMed ID: 22834671
    [No Abstract]   [Full Text] [Related]  

  • 3. Comments on "Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder".
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):597-8. PubMed ID: 17919799
    [No Abstract]   [Full Text] [Related]  

  • 4. Flunarizine- and topiramate-associated depression responsive to mirtazapine.
    Bourgeois JA; Hategan A
    Psychosomatics; 2013; 54(5):503-4. PubMed ID: 24034532
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional dyspepsia and mirtazapine.
    Lee SY; Rho SH; Choi SC
    Can J Psychiatry; 2002 Aug; 47(6):582-3. PubMed ID: 12211889
    [No Abstract]   [Full Text] [Related]  

  • 6. Mirtazapine-induced manic switch in adolescent unipolar depression.
    Goyal N; Sinha VK
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
    [No Abstract]   [Full Text] [Related]  

  • 7. Disability and borderline personality symptoms.
    Sansone RA; Hruschka J; Vasudevan A; Miller SN
    Psychosomatics; 2003; 44(5):442. PubMed ID: 12954928
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients.
    Lecei O; Lederbogen F; Gronau W; Scharnholz B; Terhardt J; Schilling C; Gilles M; Kopf D; Roth HJ; Weber-Hamann B; Deuschle M
    J Clin Psychopharmacol; 2012 Aug; 32(4):574-6. PubMed ID: 22760352
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute reversible dyskinesia induced by mirtazapine.
    Konitsiotis S; Pappa S; Mantas C; Mavreas V
    Mov Disord; 2005 Jun; 20(6):771. PubMed ID: 15732128
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute Pisa syndrome after administration of a single dose of mirtazapine.
    Méndez Guerrero A; Llamas S; Murcia FJ; Ruíz J
    Clin Neuropharmacol; 2013; 36(4):133-4. PubMed ID: 23783006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.
    Adetunji B; Basil B; Mathews M; Osinowo T
    Ann Pharmacother; 2007 Feb; 41(2):359. PubMed ID: 17244643
    [No Abstract]   [Full Text] [Related]  

  • 12. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
    Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperglycaemia secondary to mirtazapine therapy in a 37-year-old man.
    Chen R; Lopes J
    Aust N Z J Psychiatry; 2008 Nov; 42(11):990-1. PubMed ID: 18946939
    [No Abstract]   [Full Text] [Related]  

  • 14. [Optimizing antidepressant pharmacotherapy in a case of inflammatory bowel disease and major depression].
    Schmidt FM; Tennert C; Teupser D; Himmerich H
    Psychiatr Prax; 2012 Jul; 39(5):239-42. PubMed ID: 22689282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mirtazapine in an adult with refractory anorexia nervosa and comorbid depression: a case report.
    Safer DL; Darcy AM; Lock J
    Int J Eat Disord; 2011 Mar; 44(2):178-81. PubMed ID: 20127940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant switching among adherent patients treated for depression.
    Marcus SC; Hassan M; Olfson M
    Psychiatr Serv; 2009 May; 60(5):617-23. PubMed ID: 19411348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine induced mania in a woman with major depression in the absence of features of bipolarity.
    Basavraj V; Nanjundappa GB; Chandra PS
    Aust N Z J Psychiatry; 2011 Oct; 45(10):901. PubMed ID: 21692606
    [No Abstract]   [Full Text] [Related]  

  • 18. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
    Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
    Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
    [No Abstract]   [Full Text] [Related]  

  • 19. Mirtazapine-induced hepatocellular-type liver injury.
    Kang SG; Yoon BM; Park YM
    Ann Pharmacother; 2011 Jun; 45(6):825-6. PubMed ID: 21666084
    [No Abstract]   [Full Text] [Related]  

  • 20. The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs.
    Fugger G; Bartova L; Fabbri C; Fanelli G; Zanardi R; Dold M; Kautzky A; Rujescu D; Souery D; Mendlewicz J; Zohar J; Montgomery S; Serretti A; Kasper S
    J Affect Disord; 2022 Sep; 312():225-234. PubMed ID: 35691416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.